Brief: Egetis Therapeutics Q3 Loss Widens To SEK 53.9 Mln

Egetis Therapeutics AB (publ)

08/11/2022 07:11

Nov 8 (Reuters) - Egetis Therapeutics AB (publ)
 EGTX.ST :
    * Q3 REVENUES MSEK 5.1 (6.2)
    * Q3 LOSS MSEK -53.9 (-18.8)

Source text for Eikon:  ID:nMFN9DZ7qn 
Further company coverage:  EGTX.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))